{"id":"CHEMBL1017","canonicalSmiles":"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1","inchiKey":"RMMXLENWKUUMAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TELMISARTAN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Micardis","Telmisartan","Tolura"],"synonyms":["BIBR 277 SE","BIBR-277","BIBR-277 SE","BIBR-277-SE","BIBR-277SE","C09CA07","Kinzalmono","Pritor","Semintra","Telmisartan","Telmisartan actavis","Telmisartan teva"],"crossReferences":{"DailyMed":["telmisartan"],"PubChem":["137275807","144205005","170464873","26719833","26749005","49648460"],"Wikipedia":["Telmisartan"],"drugbank":["DB00966"],"chEBI":["9434"]},"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","MONDO_0005090","EFO_0003777","EFO_0008620","EFO_0000275","EFO_0003095","EFO_0000401","EFO_0000180","EFO_0004997","EFO_0000373","EFO_0000319","EFO_1001461","Orphanet_309005","EFO_0000537","EFO_0000195","MONDO_0100096","MONDO_0001134","EFO_0000712","EFO_0003884","MONDO_0004975","EFO_0000764","EFO_0000612","EFO_0004285","EFO_0000400","EFO_0005411","EFO_0003918","MONDO_0005148"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 5 approved and 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL106187","canonicalSmiles":"N=C(N)N[C@@H](C(=O)NCC(=O)N1CCC(c2cc(-c3cccc(Cl)c3Cl)n[nH]2)CC1)C1CCCCC1","inchiKey":"SSSXBBASYYVGCI-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL106187","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03957"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1093458","canonicalSmiles":"CC/C(=C(\\c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1","inchiKey":"MHJBZVSGOZTKRH-IZHYLOQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENDOXIFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-hydroxy-n-desmethyltamoxifen","Endoxifen","N-desmethyl-4-hydroxytamoxifen","NSC-749798","Z-endoxifen"],"crossReferences":{"chEBI":["80555"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1096237","canonicalSmiles":"COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C","inchiKey":"GMJWGJSDPOAZTP-MIDYMNAOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-188797","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Desacetylpaclitaxel","4-desacetylpaclitaxel 4-methyl carbonate","Bms-188797"],"crossReferences":{"drugbank":["DB12619"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL110691","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"QMBJSIBWORFWQT-DFXBJWIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORMADINONE ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Carcinogenicity"],"year":1970},"tradeNames":[],"synonyms":["Chlormadinone","Chlormadinone acetate","Lutoral","NSC-92338","Normenon"],"crossReferences":{"PubChem":["144204432","144207863","170465776","29215009","56422443","855775"],"chEBI":["31394"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom and  United States initially in 1970 due to Carcinogenicity."}
{"id":"CHEMBL111","canonicalSmiles":"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1","inchiKey":"JZCPYUJPEARBJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMONABANT","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," Never approved in the United States"],"classes":["Psychiatric toxicity"],"year":2008},"tradeNames":["Acomplia"],"synonyms":["Rimonabant","SR-14171","SR-141716","SR-141716A","SR141716","Zimulti"],"crossReferences":{"PubChem":["144205753","170465599","26757994"],"Wikipedia":["Rimonabant"],"drugbank":["DB06155"],"chEBI":["34967"]},"childChemblIds":["CHEMBL558598"],"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["HP_0001397","EFO_0004319","EFO_0006501","EFO_0004329","EFO_0003768","EFO_0000319","HP_0001824","EFO_0001073","EFO_0003843","Orphanet_309005","EFO_0007191","EFO_0000195","EFO_0003914","Orphanet_739","EFO_1001121","MONDO_0021661","EFO_0009086","MONDO_0005148","HP_0012594"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for obesity and has 15 investigational indications. It was withdrawn in European Union and  Never approved in the United States initially in 2008 due to Psychiatric toxicity."}
{"id":"CHEMBL1111","canonicalSmiles":"COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O","inchiKey":"OUJTZYPIHDYQMC-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMBRISENTAN","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Letairis","Volibris"],"synonyms":["Ambrisentan","GSK-1325760","GSK-1325760A","GSK1325760","GSK1325760A","LU-208075"],"crossReferences":{"DailyMed":["ambrisentan"],"PubChem":["144205520","170465143"],"Wikipedia":["Ambrisentan"],"drugbank":["DB06403"]},"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0001361","MONDO_0100096","Orphanet_232","Orphanet_422","EFO_0009197","EFO_0000768","MONDO_0004979","EFO_1000782","MONDO_0004933","EFO_0004264","EFO_0000537"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 4 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL11672","canonicalSmiles":"CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1","inchiKey":"SGOOQMRIPALTEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROQUINIMEX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FCF 89","FCF-89","LS 2616","LS-2616","Linomide","Roquinimex"],"crossReferences":{"PubChem":["11114093","144204502","170466254"],"drugbank":["DB11366"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1184","canonicalSmiles":"CC(=O)OCC[N+](C)(C)C.[Cl-]","inchiKey":"JUGOREOARAHOCO-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLCHOLINE CHLORIDE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL667","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Miochol","Miochol-e","Miphtel"],"synonyms":["Acetylcholine","Acetylcholine Chloride","Acetylcholine chloride","Acetylcholine chloride for injection","Choline acetate (ester) chloride","Miochol","Miochol-E","NSC-755845"],"crossReferences":{"PubChem":["11532873","170464783","26747837"],"chEBI":["2417"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["MONDO_0005129","EFO_1001461","HP_0000616"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for cataract and miosis."}
{"id":"CHEMBL1200339","canonicalSmiles":"CNC[C@H](O)c1cccc(O)c1.Cl","inchiKey":"OCYSGIYOVXAGKQ-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLEPHRINE HYDROCHLORIDE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1215","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afrin 4 hour nasal spray","Biomydrin","Biorphen","Fenilfar","Fenox","Mydfrin","Nazex","Neo-synephrine","Neosynephrine","Nostril","Nurofen sinus pain relief","Phenylephrine hydrochloride","Prefrin","Vazculep"],"synonyms":["Metaoxedrine chloride","NSC-757273","Phenylephrine HCl","Phenylephrine hydrochloride"],"crossReferences":{"DailyMed":["phenylephrine%20hydrochloride"],"PubChem":["144204448","144208459","144213163","170465356","26751602","50106782","855560"],"chEBI":["8094"]},"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0004610","EFO_0008521","HP_0000989","EFO_0007486","EFO_0006834","EFO_0004269","EFO_0007533","MONDO_0005271","EFO_0000319","HP_0001742","EFO_0007214","MONDO_0024355","EFO_0000178","EFO_0000544","MONDO_0005129","EFO_0009552","EFO_0003956","EFO_0005251"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 9 approved and 9 investigational indications."}
{"id":"CHEMBL1200346","drugType":"Small molecule","blackBoxWarning":true,"name":"GADODIAMIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omniscan"],"synonyms":["GDDTPA-BMA","Gadodiamide","Gadodiamide anhydrous","S-041"],"crossReferences":{"DailyMed":["gadodiamide"],"DrugCentral":["4494"],"Wikipedia":["Gadodiamide"],"chEBI":["37333"]},"childChemblIds":["CHEMBL3182387"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200589","canonicalSmiles":"CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1.Cl","inchiKey":"SVSFIELZISOJDT-XRZFDKQNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTIAM HYDROCHLORIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1296","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceradon","Pansporin"],"synonyms":["ABBOTT-48999","CGP-14221/E","Cefotiam dihydrochloride","Cefotiam hcl","Cefotiam hexetil hydrochloride","Cefotiam hydrochloride","NSC-758164","SCE 963","SCE-963"],"crossReferences":{"PubChem":["144204281","170465103","56463238"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988."}
{"id":"CHEMBL1200830","drugType":"Small molecule","blackBoxWarning":true,"name":"FERROUS SULFATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Feosol","Feospan","Fer-In-Sol","Fero-gradumet","Ferr sulf, dried","Ferrograd","Mol-iron","Monsels Solution","Natabec","Slow-fe"],"synonyms":["Copperas","Fer-in-sol","Ferrosi sulfas","Ferrous ii sulfate heptahydrate","Ferrous sulfate","Ferrous sulfate (1:1)","Ferrous sulfate anhydrous","Ferrous sulfate heptahydrate","Ferrous sulfate hydrate","Ferrous sulfate, anhydrous","Ferrous sulfate, exsiccated","Ferrous sulfate,dried","Ferrous sulphate","Ferrous sulphate (1:1)","Ferrous sulphate anhydrous","Ferrous sulphate heptahydrate","Ferrous sulphate, anhydrous","Ferrum sulphuricum","Fesofor","Green vitriol","Haemofort","Iron (as ferrous sulfate)","Iron (as sulphate)","Iron sulfate (feso4)","Iron sulphate (feso4)","Iron vitriol","Ironate","NSC-146177","NSC-57631","Presfersul","Sulferrous"],"crossReferences":{"DrugCentral":["4528"],"PubChem":["144209778"],"Wikipedia":["Iron(II)_sulfate"],"chEBI":["75832"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for anemia (phenotype) and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200977","canonicalSmiles":"CC(O)C(=O)O.Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1","inchiKey":"VWUPWEAFIOQCGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILRINONE LACTATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL189","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Milrinone lactate","Primacor"],"synonyms":["Milrinone lactate"],"crossReferences":{"DailyMed":["milrinone%20lactate"],"chEBI":["34850"]},"linkedTargets":{"rows":["ENSG00000172572"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","HP_0004308"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for heart failure and ventricular arrhythmia."}
{"id":"CHEMBL1200994","drugType":"Small molecule","blackBoxWarning":false,"name":"GALLIUM CITRATE GA 67","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110553","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gallium citrate ga 67","Neoscan"],"synonyms":["67ga","Gallium ((sup 67)ga) citrate","Gallium (67 ga)","Gallium (67 ga) citrate","Gallium (67ga) citrate","Gallium 67 citrate","Gallium Citrate (67Ga)","Gallium citrate ga 67","Gallium citrate ga-67","Gallium citrate, ga-67","Gallium citrate,ga-67","Gallium ga-67 citrate","Gallium-(sup 67)ga citrate (1:1)","Gallium-67 citrate","Gallium-67ga citrate (1:1)"],"crossReferences":{"DrugCentral":["4560"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and has 1 investigational indication."}
{"id":"CHEMBL1201013","canonicalSmiles":"O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]","inchiKey":"ZJEFYLVGGFISGT-VRZXRVJBSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"OLSALAZINE SODIUM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL425","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dipentum"],"synonyms":["Ads","Azodisal sodium","CJ 91B","CJ-91B","Disodium azodisalicylate","Olsalazine disodium salt","Olsalazine sodium","Sodium azodisalicylate","Sodium olsalazine"],"crossReferences":{"DailyMed":["olsalazine%20sodium"]},"linkedTargets":{"rows":["ENSG00000132170","ENSG00000012779","ENSG00000073756","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for ulcerative colitis."}
{"id":"CHEMBL1201159","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl","inchiKey":"LHCBOXPPRUIAQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENTANYL HYDROCHLORIDE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL596","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ionsys"],"synonyms":["Fentanyl hcl","Fentanyl hydrochloride"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2006 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201218","canonicalSmiles":"Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](OC=O)c3ccccc3)[C@H]2SC1","inchiKey":"RRJHESVQVSRQEX-SUYBPPKGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAMANDOLE NAFATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mandol"],"synonyms":["106223","Cefamandole nafate"],"crossReferences":{"PubChem":["124894241"],"drugbank":["DB14725"],"chEBI":["53654"]},"childChemblIds":["CHEMBL1618"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978 and has 1 investigational indication."}
{"id":"CHEMBL1201281","canonicalSmiles":"O=C(O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1","inchiKey":"LIRCDOVJWUGTMW-ZWNOBZJWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORAMPHENICOL SUCCINIC ACID","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chloramphenicol succinate"],"crossReferences":{"DailyMed":["chloramphenicol%20sodium%20succinate"],"drugbank":["DB07565"]},"childChemblIds":["CHEMBL1200729"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 4 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201300","canonicalSmiles":"CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I","inchiKey":"UXIGWFXRQKWHHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOTHALAMIC ACID","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iotalamic acid","Iothalamate","Iothalamic acid","MI-216","NSC-759891"],"crossReferences":{"DailyMed":["iothalamate%20meglumine","iothalamate%20sodium%20i-125"],"drugbank":["DB09133"]},"childChemblIds":["CHEMBL1201125","CHEMBL2104998","CHEMBL2106318","CHEMBL1097620","CHEMBL1201123"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201473","drugType":"Small molecule","blackBoxWarning":false,"name":"COLESEVELAM HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cholestagel","Welchol"],"synonyms":["Colesevelam","Colesevelam hcl","Colesevelam hydrochloride","GT-31-104HB","GT31-104HB","IW-3718","NSC-760126"],"crossReferences":{"DailyMed":["colesevelam%20hydrochloride"],"DrugCentral":["4405"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for type 2 diabetes mellitus and familial hypercholesterolemia and has 6 investigational indications."}
{"id":"CHEMBL1213446","canonicalSmiles":"O=c1c2c3c(sc2ncn1Cc1nnn[nH]1)CCCC3","inchiKey":"QSBQXAOOVSQABJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213446","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06889"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL122","canonicalSmiles":"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1","inchiKey":"RZJQGNCSTQAWON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ROFECOXIB","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2004},"tradeNames":["Vioxx"],"synonyms":["M01AH02","MK-0966","MK-966","MK0966","NSC-720256","NSC-758705","Rofecoxib","TRM-201"],"crossReferences":{"PubChem":["144204983","174007305","26748942","49665949","535364"],"Wikipedia":["Rofecoxib"],"drugbank":["DB00533"],"chEBI":["8887"]},"childChemblIds":["CHEMBL4465601"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000280","EFO_0000685","EFO_0003897","EFO_0005406","EFO_0003843","MONDO_0008315","EFO_0005755","EFO_0003060","EFO_1001951","MONDO_0000147","HP_0003040","Orphanet_733","MONDO_0004975","EFO_0004616","EFO_0000326","EFO_0003833","MONDO_0005178"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for rheumatic disease and has 12 investigational indications. It was withdrawn in United States  in 2004 due to Cardiotoxicity and  Neurotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1230988","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@@H]4CC(=O)CC[C@]34C)[C@@H]1CCC2=O","inchiKey":"RAJWOBJTTGJROA-QJISAEMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230988","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["85148342"],"drugbank":["DB07375"],"chEBI":["16985"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231178","canonicalSmiles":"O=[N+]([O-])c1ccc(OP(=O)(O)Oc2ccc([N+](=O)[O-])cc2)cc1","inchiKey":"MHSVUSZEHNVFKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231178","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["89855347"],"drugbank":["DB07418"],"chEBI":["3122"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234443","canonicalSmiles":"O=S(=O)(O)CCCN1CCOCC1","inchiKey":"DVLFYONBTKHTER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234443","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212463"],"drugbank":["DB03434"],"chEBI":["44115"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235116","canonicalSmiles":"CCn1c2ccccc2c2cc(CNC)ccc21","inchiKey":"LBPNOEAFWYTTEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235116","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08363"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1474129","canonicalSmiles":"Nc1cc(C(Cl)=C(Cl)Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O","inchiKey":"QOVTVIYTBRHADL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORSULON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clorsulon","Clorsuron","Curatrem","MK-401","NSC-758901"],"crossReferences":{"PubChem":["11112808","124893809","144204220","144206558","170466229","26750030","56463526"],"drugbank":["DB11389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1565476","canonicalSmiles":"CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O","inchiKey":"MPHPHYZQRGLTBO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APAZONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rheumox","Rheumox 600"],"synonyms":["AHR-3018","Apazone","Apazone dihydrate","Azapropazone","Azapropazone dihydrate","Cinnopropazone","MI-85","MI-85DI","NSC-102824","Prolixan"],"crossReferences":{"PubChem":["144204120","56463151"],"chEBI":["38010"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL1567","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O","inchiKey":"LBWFXVZLPYTWQI-IPOVEDGCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUNITINIB MALATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL535","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sunitinib malate","Sutent"],"synonyms":["PHA-290940AD","SU-010398","SU-011248 L-MALATE SALT","SU010398","SU011248 L-MALATE SALT","Sunitinib l-malate","Sunitinib malate","Sutent"],"crossReferences":{"DailyMed":["sunitinib%20malate"]},"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000157404","ENSG00000113721","ENSG00000182578","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0003869","EFO_1000403","EFO_0000558","EFO_0000681","EFO_1000984","EFO_0000632","EFO_1001951","EFO_0000588","MONDO_0003268","MONDO_0008903","EFO_0000182","EFO_0000501","EFO_0000641","MONDO_0015277","EFO_0000514","EFO_0002618","EFO_0000220","EFO_0000349","EFO_1001968","MONDO_0004986","MONDO_0008315","Orphanet_398934","MONDO_0002691","EFO_1000576","MONDO_0044787","EFO_0001378","EFO_0002938","EFO_1001901","MONDO_0004192","EFO_0007416","EFO_1001465","MONDO_0007254","MONDO_0002087","EFO_0000350","MONDO_0020654","MONDO_0001187","Orphanet_892","MONDO_0002158","EFO_1000044","EFO_0006352","EFO_1001974","EFO_0000673","EFO_0002499","EFO_1000042","EFO_0002617","EFO_0000616","EFO_0003897","EFO_0007331","Orphanet_44890","EFO_0000403","MONDO_0007576","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0000640","EFO_0003865","EFO_0006861","EFO_0000095","EFO_0000702","MONDO_0002367","MONDO_0024880","EFO_0000519","MONDO_0044926"],"count":63},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 5 approved and 50 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL157548","canonicalSmiles":"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1","inchiKey":"QMLVECGLEOSESV-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANOFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Advocin","Danofloxacin"],"crossReferences":{"PubChem":["144205730","170466637","26757967"],"Wikipedia":["Danofloxacin"],"drugbank":["DB11393"]},"childChemblIds":["CHEMBL2106153"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15967","canonicalSmiles":"c1cn[nH]c1","inchiKey":"WTKZEGDFNFYCGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1H-Pyrazole","Pyrazole"],"crossReferences":{"PubChem":["99139"],"Wikipedia":["Pyrazole"],"drugbank":["DB02757"],"chEBI":["17241"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL161","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(O)nn3C)CS[C@H]12)c1csc(N)n1","inchiKey":"VAAUVRVFOQPIGI-SPQHTLEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTRIAXONE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ceftriaxon","Ceftriaxone"],"crossReferences":{"DailyMed":["ceftriaxone%20sodium"],"Wikipedia":["Ceftriaxone"],"drugbank":["DB01212"],"chEBI":["29007"]},"childChemblIds":["CHEMBL4101392","CHEMBL1200995","CHEMBL3183968"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 9 approved and 21 investigational indications."}
{"id":"CHEMBL1615372","canonicalSmiles":"Cl.O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1","inchiKey":"NEKCRUIRPWNMLK-SCIYSFAVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LURASIDONE HYDROCHLORIDE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237021","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Latuda"],"synonyms":["Lurasidone hcl","Lurasidone hydrochloride","SM-13496"],"crossReferences":{"DailyMed":["lurasidone%20hydrochloride"],"chEBI":["70732"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000289","EFO_0009963"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1625","canonicalSmiles":"COc1ccc(C(=O)c2ccccc2)c(O)c1","inchiKey":"DXGLGDHPHMLXJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYBENZONE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uvinul m40"],"synonyms":["Advastab 45","Benzophenone-3","NSC-7778","Ongrostab hmb","Oxybenzone","Tinosorb b 3","Uvinul 40","Viosorb 110"],"crossReferences":{"PubChem":["104171298","11112288","124882190","144203969","144209183","144213169","170465010","17389510","26747192","26752298","49718129","856513"],"Wikipedia":["Oxybenzone"],"drugbank":["DB01428"],"chEBI":["34283"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for freckles."}
{"id":"CHEMBL1696","canonicalSmiles":"CNCCCN1c2ccccc2CCc2ccccc21.Cl","inchiKey":"XAEWZDYWZHIUCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESIPRAMINE HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL72","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desipramine hydrochloride","Norpramin","Pertofran","Pertofrane"],"synonyms":["18-8181","DMI","Desipramine hcl","Desipramine hydrochloride","EX 4355","EX-4355","G-35020","JB-8181","NSC-114901","RMI 9,384A","RMI-9384A"],"crossReferences":{"DailyMed":["desipramine%20hydrochloride"],"PubChem":["144203680","170465424","26732610","26747493","26747494","50106122","50106123","50106124","855832","858256"],"chEBI":["4449"]},"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0000702","EFO_0003761","HP_0003418"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for unipolar depression and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1718","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl","inchiKey":"RGPDIGOSVORSAK-STHHAXOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALOXONE HYDROCHLORIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL80","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evzio","Evzio (autoinjector)","Kloxxado","Nalone","Naloxone","Naloxone hydrochloride","Narcan","Narcan neonatal","Narconil","Prenoxad"],"synonyms":["Anhydrous naloxone hydrochloride","EN-15304","NIH 7890","NSC-757109","Naloxone hcl","Naloxone hydrochloride","Naloxone hydrochloride anhydrous","Narcanti"],"crossReferences":{"DailyMed":["naloxone%20hydrochloride"],"PubChem":["11532915"],"chEBI":["31892"]},"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0006834","EFO_0003761","EFO_0005611","EFO_0004699","EFO_0010702","EFO_0003843","MONDO_0004565","HP_0002019"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL1743064","drugType":"Antibody","blackBoxWarning":false,"name":"ROBATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["19D12","Robatumumab","SCH 717454","SCH-717454"],"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1801250","canonicalSmiles":"O=C(NO)c1cnc(N2C[C@H]3[C@H](NCc4ccc5cc(F)ccc5n4)[C@H]3C2)nc1","inchiKey":"QRGHOAATPOLDPF-VQFNDLOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NANATINOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHR-3996","Chr 3996","Hdac inhibitor chr-3996","Nanatinostat","VRX-3996"],"crossReferences":{"drugbank":["DB15419"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1863515","drugType":"Enzyme","blackBoxWarning":false,"name":"GLUCARPIDASE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Voraxaze"],"synonyms":[".gamma.-glu-x carboxypeptidase","Carboxypeptidase g2","Folate hydrolase g2","Glucarpidase","Voraxaze"],"crossReferences":{"DailyMed":["glucarpidase"],"DrugCentral":["5138"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 6 investigational indications."}
{"id":"CHEMBL1908843","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOFOSVESET","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["D-gulonic acid","Gadofosveset","MS-325"],"crossReferences":{"DrugCentral":["3258"]},"childChemblIds":["CHEMBL1908362"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008. This drug has a black box warning from the FDA."}
{"id":"CHEMBL191910","canonicalSmiles":"O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccc(I)cc1","inchiKey":"CYYIBMGIJWXZEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08284"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL206468","canonicalSmiles":"OC[C@H]1CNC[C@@H](O)[C@@H]1O","inchiKey":"QPYJXFZUIJOGNX-HSUXUTPPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFEGOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afegostat","Isofagomine"],"crossReferences":{"PubChem":["85267413"],"drugbank":["DB04545"]},"childChemblIds":["CHEMBL2105671"],"linkedTargets":{"rows":["ENSG00000177628"],"count":1},"linkedDiseases":{"rows":["Orphanet_355"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL20945","canonicalSmiles":"O=[N+]([O-])c1cccc(B(O)O)c1","inchiKey":"ZNRGSYUVFVNSAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Nitrophenyl Boronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Nitrophenyl Boronic Acid","3-Nitrophenylboronic Acid","M-Nitophenyl Boronic Acid"],"crossReferences":{"PubChem":["26753147"],"drugbank":["DB02797"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105161","canonicalSmiles":"CCCCOCCOC(=O)c1cccnc1","inchiKey":"IZJRISIINLJVBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOBOXIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-butoxyethyl nicotinate","Butoxyethyl nicotinate","Nicoboxil"],"crossReferences":{"PubChem":["170465989"],"drugbank":["DB12911"],"chEBI":["32322"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105719","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O","inchiKey":"BSPLGGCPNTZPIH-IPZCTEOASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DACOMITINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110732","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vizimpro"],"synonyms":["Dacomitinib","Dacomitinib hydrate","Dacomitinib monohydrate","PF-00299804-03","Pf-00299804"],"crossReferences":{"DailyMed":["dacomitinib"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for non-small cell lung carcinoma."}
{"id":"CHEMBL2105829","canonicalSmiles":"CCOC(=O)C1=C(c2ccc(-n3c(C)nc4cnccc43)cc2)NC(C)=C(C(=O)Nc2ccccn2)[C@H]1c1ccccc1Cl","inchiKey":"ODRYSCQFUGFOSU-SSEXGKCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MODIPAFANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Modipafant","UK-80067"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106573","canonicalSmiles":"CCN(CC)C(C)C=C(c1cccs1)c1cccs1","inchiKey":"CBYWMRHUUVRIAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLTHIAMBUTENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["191c49","Acscn-9616","Diethylthiambutene","IDS-ND-006","Nih-4185","Thiambutene"],"crossReferences":{"drugbank":["DB01533"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107636","canonicalSmiles":"Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cc(Cl)c(=O)c(Cl)c4)[C@H]3SC2)s1","inchiKey":"VTLCNEGVSVJLDN-MLGOLLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAZEDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefazedone"],"crossReferences":{"drugbank":["DB13778"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107760","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)/C=C/c2ccccc2)nc(-c2ncccn2)nc1OC","inchiKey":"LONWRQOYFPYMQD-DTQAZKPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBENTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HE-11","Nebentan","Nebentan potassium","YM-598","Ym598"],"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["EFO_0000673","MONDO_0008315"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107762","canonicalSmiles":"CCCN(c1ccncc1F)n1cc(C)c2ccccc21","inchiKey":"BTDHTARYCBHHPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERISPIRDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HP-184","HP184","Nerispirdine","Nerispirdine hydrochloride"],"crossReferences":{"drugbank":["DB12714"]},"childChemblIds":["CHEMBL3585642"],"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000053918","ENSG00000129159","ENSG00000168263","ENSG00000140015","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000153253","ENSG00000111262","ENSG00000102057","ENSG00000136546","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000168356","ENSG00000135519","ENSG00000158445","ENSG00000168418","ENSG00000089558","ENSG00000177301","ENSG00000151079","ENSG00000144285","ENSG00000166006","ENSG00000169432","ENSG00000104848","ENSG00000156486","ENSG00000136531","ENSG00000171385","ENSG00000184611"],"count":50},"linkedDiseases":{"rows":["MONDO_0005301","EFO_1001919"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108165","drugType":"Unknown","blackBoxWarning":false,"name":"VALERIAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4M98M04Z3Z","7D1DL7VY9S","Chinese valerian","Chinese valerian whole","Common valerian whole","FEMA NO. 3099","FMM0HE453U","Garden heliotrope whole","Garden valerian whole","Indian valerian whole","Japanese valerian whole","Mexican valerian whole","Pacific valerian whole","Powdered valerian extract","Sugandhabala whole","Tagara whole","Valerian","Valerian whole","Valeriana officinalis","Valeriana officinalis extract","Valeriana officinalis rhizome dry extract","Valeriana officinalis root","Valeriana officinalis root extract","Valeriana officinalis root tincture","Valeriana officinalis root with rhizome","Valeriana officinalis whole","Valeriana pseudofficinalis whole"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108400","drugType":"Protein","blackBoxWarning":false,"name":"EMFILERMIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM-424","AM424","Emfilermin"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109418","drugType":"Antibody","blackBoxWarning":false,"name":"3F8","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3F8","3f8"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109487","drugType":"Antibody","blackBoxWarning":false,"name":"RG-1512","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-1512"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109527","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-578","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-578","Medi-578"],"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["EFO_0003843","MONDO_0005178"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109587","drugType":"Antibody","blackBoxWarning":false,"name":"AZ9773","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-9773","AZ9773"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109626","drugType":"Antibody","blackBoxWarning":false,"name":"ALG-991","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALG-991","Alg-991"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2110587","canonicalSmiles":"O=C(NS(=O)(=O)c1ccc(Br)s1)c1ccc(Cl)cc1Cl","inchiKey":"WWONFUQGBVOKOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TASISULAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-573636","Ly573636","Tasisulam"],"crossReferences":{"drugbank":["DB11941"]},"childChemblIds":["CHEMBL2103823"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL2179582","canonicalSmiles":"CC1(C)C(=O)N(C(=O)NCC2CCN(CC3(O)CCOCC3)CC2)c2cc(F)ccc21","inchiKey":"AGMOFKKOVMRGAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03382792","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-03382792"],"crossReferences":{"drugbank":["DB12949"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218878","canonicalSmiles":"COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC.O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"DQOGWKZQQBYYMW-LQGIGNHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETREXATE GLUCURONATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL119","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neutrexin"],"synonyms":["NSC-352122","Trimetrexate d-glucuronate","Trimetrexate glucuronate"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 4 investigational indications."}
{"id":"CHEMBL2338397","canonicalSmiles":"C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@@H]1C(=O)N(CCO)c2ncccc2-c2ccccc21","inchiKey":"YCBAQKQAINQRFW-UGSOOPFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRENIGACESTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crenigacestat","JSMD-194","JSMD194","LY-3039478","LY3039478"],"crossReferences":{"drugbank":["DB12050"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL258040","canonicalSmiles":"O=C(Cc1ccc(N2CCCCC2)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12","inchiKey":"ZXYIRNXOAJYLCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL258040","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07220"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259420","canonicalSmiles":"CC(C)(C)n1nc(Cc2cccc(O)c2)c2c(N)ncnc21","inchiKey":"QMAIQPBRCNEJAT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08461"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL283120","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC","inchiKey":"YJGVMLPVUAXIQN-HAEOHBJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXL-1717","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AXL-1717","Axl-1717","Axl1717","NSC-36407","Picropodophyllin","Picropodophyllotoxin","Podophyllotoxin picropodophyllin"],"crossReferences":{"PubChem":["29216394"],"drugbank":["DB12802"],"chEBI":["75251"]},"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001642","EFO_0000571","EFO_1001465","EFO_0002499","EFO_0002501","EFO_0002500","EFO_0000707","EFO_0003060"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL288441","canonicalSmiles":"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl","inchiKey":"UBPYILGKFZZVDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOSUTINIB","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bosulif"],"synonyms":["Bosutinib","Bosutinib (as monohydrate)","Bosutinib hydrate","Bosutinib monohydrate","SK-606","SKI-606"],"crossReferences":{"DailyMed":["bosutinib%20monohydrate"],"PubChem":["124950167"],"Wikipedia":["Bosutinib"],"drugbank":["DB06616"],"chEBI":["39112"]},"childChemblIds":["CHEMBL2131134"],"linkedTargets":{"rows":["ENSG00000101336","ENSG00000097007","ENSG00000186716","ENSG00000254087","ENSG00000197122"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0000220","HP_0000726","MONDO_0008170","MONDO_0007254","EFO_1000131","EFO_0000222","MONDO_0002087","EFO_1001496","EFO_0000305","EFO_0003060","MONDO_0001187","EFO_0000565","EFO_1000581","MONDO_0002586","EFO_0000339","EFO_0000588","MONDO_0002974","MONDO_0004976","EFO_0000519"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for chronic myelogenous leukemia and neoplasm and has 19 investigational indications."}
{"id":"CHEMBL295698","canonicalSmiles":"CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1","inchiKey":"XMAYWYJOQHXEEK-ZEQKJWHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOKETOCONAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Extina","Ketosidin","Ketozole","Nizoral","Nizoral A-D","Panfungol","Xolegel"],"synonyms":["(-)-(2s,4r)-ketoconazole","2s,4r ketoconazole","2s,4r-ketoconazole","COR-003","COR003","DIO-902","Ketoconazole, (2s,4r)-","Levoketoconazole","Nizoral","Normocort","R-41400"],"crossReferences":{"PubChem":["11111347","11112822","124882653","124882654"],"drugbank":["DB05667"],"chEBI":["47518"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3039538","drugType":"Protein","blackBoxWarning":false,"name":"TRENONACOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ixinity[tm]"],"synonyms":["IB-1001","IB1001","Trenonacog alfa"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL307782","canonicalSmiles":"Nc1cccc(C(=O)O)c1","inchiKey":"XFDUHJPVQKIXHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-AMINOBENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Amino-Benzoic Acid","3-Aminobenzoic Acid","M-Aminobenzoic Acid"],"crossReferences":{"PubChem":["56422198","855737"],"Wikipedia":["3-Aminobenzoic_acid"],"drugbank":["DB02054"],"chEBI":["42682"]},"childChemblIds":["CHEMBL1762659"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3109802","canonicalSmiles":"COc1ncnc(Cn2cc(C(=O)NCCO)c3ncc(C)cc32)c1C","inchiKey":"VDRYGTNDKXIPSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TBA-7371","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-7371","TBA-7371","Tba-7371"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137317","canonicalSmiles":"Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"RWIVSVMMGFFZIJ-VWDRLOGHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SONIDEGIB PHOSPHATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2105737","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Odomzo"],"synonyms":["Erismodegib phosphate","Sonidegib diphosphate","Sonidegib phosphate"],"crossReferences":{"DailyMed":["sonidegib%20phosphate"]},"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0004193"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for basal cell carcinoma. This drug has a black box warning from the FDA."}
{"id":"CHEMBL323668","canonicalSmiles":"COc1cc2c(c(OC)c1OC)-c1ccc(=O)c(O)cc1C(NC(C)=O)CC2","inchiKey":"PRGILOMAMBLWNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL323668","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26749960","49670650"],"drugbank":["DB15534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL327097","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)O)cc1NC(=O)CO","inchiKey":"CRHJDPGLFDNPOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL327097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04565"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL329592","canonicalSmiles":"CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1","inchiKey":"CEAZRRDELHUEMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL329592","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006261","174006636"],"drugbank":["DB00798"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL330498","canonicalSmiles":"COc1cc([C@H]2C3=C(COC3=O)Cc3cc4c(cc32)OCO4)cc(OC)c1OC","inchiKey":"OPGVEBTYBAOEHZ-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL330498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15590"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL352531","canonicalSmiles":"O=[N+]([O-])c1ccc(-c2ccccc2)cc1","inchiKey":"BAJQRLZAPXASRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Nitro-Biphenyl","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Nitro-Biphenyl"],"crossReferences":{"drugbank":["DB12300"],"chEBI":["82504"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544962","drugType":"Small molecule","blackBoxWarning":false,"name":"CT-1578","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-1578","Ct-1578","ONX 0805","ONX-0805","SB-1578","SB1578","Sb-1578","Sb1578"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545100","drugType":"Small molecule","blackBoxWarning":false,"name":"ASP7991","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asp7991"],"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_1001173"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545184","canonicalSmiles":"CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O","inchiKey":"ANIAZGVDEUQPRI-ZJQCGQFWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VELCALCETIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parsabiv"],"synonyms":["AMG-416","Amg416","Etelcalcetide","KAI-4169","ONO-5163","Telcalcetide","Velcalcetide"],"crossReferences":{"DailyMed":["etelcalcetide"],"drugbank":["DB12865"]},"childChemblIds":["CHEMBL3545183"],"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0003884","EFO_0005754"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL3545187","canonicalSmiles":"O=C(/C=C\\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1","inchiKey":"OPAKEJZFFCECPN-XQRVVYSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERDINEXOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KPT-335","Verdinexor"],"crossReferences":{"drugbank":["DB12207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545285","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-999","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["XL-999","Xl 999","Xl-999"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000102755","ENSG00000077782","ENSG00000160867","ENSG00000037280","ENSG00000113721","ENSG00000157404","ENSG00000122025"],"count":11},"linkedDiseases":{"rows":["MONDO_0008170","EFO_0000681","EFO_0000222","EFO_0001378","EFO_0003060","EFO_0000311","EFO_1001951"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL359020","canonicalSmiles":"O=C(Nc1cc([C@@H]2CCCN2)[nH]n1)Nc1cccc2c1[C@@H]1CCCN1C2=O","inchiKey":"IWOOJEZSDPRYAZ-WFASDCNBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL359020","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06976"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3653256","canonicalSmiles":"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1","inchiKey":"AGBSXNCBIWWLHD-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIREMADLIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hdm 201","NVP-HDM 201","Siremadlin"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707362","canonicalSmiles":"CC(C(=O)N1c2ccccc2Sc2ccccc21)N(C)C","inchiKey":"POZJNEBUHLZROM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLAMINOPROPIONYLPHENOTHIAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethylaminopropionylphenothiazine"],"crossReferences":{"drugbank":["DB13672"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL374361","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"AHCYMLUZIRLXAA-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-deoxy-UTP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-deoxy-UTP"],"crossReferences":{"drugbank":["DB02333"],"chEBI":["17625"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989504","canonicalSmiles":"N[C@@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn([C@@H]4C[C@@H]4F)c3c2Cl)CC12CC2.O","inchiKey":"ANCJYRJLOUSQBW-JJZGMWGRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAFLOXACIN","maximumClinicalTrialPhase":2,"parentId":"CHEMBL108821","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DU-6859A","Sitafloxacin","Sitafloxacin hydrate","Sitafloxacin sesquihydrate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989725","canonicalSmiles":"N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1.NC(CO)(CO)CO.NC(CO)(CO)CO","inchiKey":"JJOFNSLZHKIJEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LODOXAMIDE TROMETHAMINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201266","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alomide","Alomide allergy"],"synonyms":["Lodoxamide trometamol","Lodoxamide tromethamine","Lodoxamide tromethamine salt","U-42,585E","U-42585E"],"crossReferences":{"DailyMed":["lodoxamide%20tromethamine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993."}
{"id":"CHEMBL3990018","drugType":"Antibody","blackBoxWarning":false,"name":"CERGUTUZUMAB AMUNALEUKIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cergutuzumab amunaleukin","RG-7813","RG7813","RO-6895882","RO6895882"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL401377","canonicalSmiles":"Brc1cnn2c(NCc3ccncc3)cc(-c3ccccc3)nc12","inchiKey":"JECHSYMSTXETFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401377","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07210"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4068108","canonicalSmiles":"CC1=C(CC(=O)NCc2ccccc2)c2cc(F)ccc2/C1=C\\c1ccncc1","inchiKey":"NVCAMOJXQVJSOM-XKZIYDEJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-461","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4243974"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL408350","canonicalSmiles":"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O","inchiKey":"RZHKDBRREKOZEW-AAXZNHDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDOTREOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dotatoc","Edotreotide","SMT 487","SMT-487"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297207","drugType":"Small molecule","blackBoxWarning":false,"name":"STANNSOPORFIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stanate"],"synonyms":["B-992","B992","Mesoporphyrin tin","Stanate","Stannsoporfin","Tin mesoporphyrin"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297280","canonicalSmiles":"N[C@@H](CNC(=O)CC[C@@H](NC(=O)c1ccc(NCc2c[nH]c3ncnc(=O)c-3n2)cc1)C(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O","inchiKey":"YZSIZVRFVQKMJU-RDGPPVDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETARFOLATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EC-20","Etarfolatide"],"crossReferences":{"drugbank":["DB11810"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297334","canonicalSmiles":"O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)c1ccc([18F])nc1)C(=O)O)C(=O)O","inchiKey":"OLWVRJUNLXQDSP-MVBOSPHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIFLUFOLASTAT F18","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4299851","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pylarify"],"synonyms":["(18f)dcfpyl","18f-dcfpyl","Dcfpyl f-18","Piflufolastat f-18","Piflufolastat f18"],"crossReferences":{"drugbank":["DB14805"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and has 3 investigational indications."}
{"id":"CHEMBL4297432","canonicalSmiles":"O=C(O)CN1C(=O)[C@@H](NC(=O)C2(C[C@@H](CCc3cccc4ccccc34)C(=O)O)CCCC2)CCc2ccccc21","inchiKey":"LOFDNSDPZTVIIO-VPUSJEBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SLV-334","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SLV334","Slv-334","Slv334"],"crossReferences":{"drugbank":["DB15356"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297470","canonicalSmiles":"COc1cc(F)ccc1-c1c(C)sc2cnc(Nc3cnn(C4CCNCC4)c3)nc12","inchiKey":"AVIOBQFPAGEICQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAX-40279","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MAX-40279","Max-40279"],"crossReferences":{"drugbank":["DB15191"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297491","canonicalSmiles":"C=CCN1CC(=O)N2[C@@H](Cc3ccc(O)cc3F)C(=O)N(Cc3cccc(N4CC(N5CCN(CC)CC5)C4)n3)C[C@@H]2N1C(=O)NCc1ccccc1","inchiKey":"ZGNKNLOBYFTGRG-GIWKVKTRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-7386","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7386","E7386"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297528","canonicalSmiles":"Cc1cn2nc(-c3cc(=O)n4cc(N5CCNC6(CC6)C5)ccc4n3)cc(C)c2n1","inchiKey":"ASKZRYGFUPSJPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RISDIPLAM","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evrysdi"],"synonyms":["RG-7916","RG7916","RO-7034067","RO7034067","Risdiplam"],"crossReferences":{"drugbank":["DB15305"]},"linkedTargets":{"rows":["ENSG00000205571"],"count":1},"linkedDiseases":{"rows":["EFO_0008525","EFO_1000096"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for spinal muscular atrophy and atrophy."}
{"id":"CHEMBL4298051","drugType":"Unknown","blackBoxWarning":false,"name":"HAFNIUM OXIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hafnium oxide","NBTXR3","NSC-158931","Nbtxr3"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298093","drugType":"Antibody","blackBoxWarning":false,"name":"SEMORINEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MTAU-9937A","MTAU9937A","RO-7105705","RO7105705","Ro7105705","Semorinemab"],"linkedTargets":{"rows":["ENSG00000186868"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298102","drugType":"Antibody","blackBoxWarning":false,"name":"VUNAKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SHR-1314","Shr-1314","Vunakizumab"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298135","drugType":"Unknown","blackBoxWarning":false,"name":"NASTORAZEPIDE CALCIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nastorazepide calcium","Nastorazepide hemicalcium","R-(-)-z-360","Z-360"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL43","canonicalSmiles":"COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12","inchiKey":"XCPGHVQEEXUHNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMSACRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amsidyl"],"synonyms":["Acridinylanisidide","Amekrin","Amsacrine","Amsidil","Amsidine","CI-880","Lamasine","M-AMSA","NCI-249992","NSC-156303","NSC-249992","SN-11841","SN-21429"],"crossReferences":{"PubChem":["11110803","137181","50110958"],"Wikipedia":["Amsacrine"],"drugbank":["DB00276"],"chEBI":["2687"]},"childChemblIds":["CHEMBL1256655","CHEMBL3229103","CHEMBL540070"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198","EFO_0000616","EFO_0000222"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 3 investigational indications."}
{"id":"CHEMBL444965","canonicalSmiles":"CC(=O)OO","inchiKey":"KFSLWBXXFJQRDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHANEPEROXOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Peracetic Acid"],"crossReferences":{"PubChem":["144205955"],"Wikipedia":["Peracetic_acid"],"drugbank":["DB14556"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL44857","canonicalSmiles":"CCCOC(C)=O","inchiKey":"YKYONYBAUNKHLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETIC ACID PROPYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetic Acid Propyl Ester"],"crossReferences":{"PubChem":["144209210"],"Wikipedia":["Propyl_acetate"],"drugbank":["DB01670"],"chEBI":["40116"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL452800","canonicalSmiles":"CCCN1CCC(c2nc3cccc(C(N)=O)c3[nH]2)CC1","inchiKey":"KXSIHXHEHABEJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"A-620223","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-620223"],"crossReferences":{"drugbank":["DB07330"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594404","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCC(N(C)C6([C@@H]7CCN(c8c(F)cn9c(=O)c(C(=O)O)cc(C%10CC%10)c9c8C)C7)CC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C","inchiKey":"OPZFMLLAJBIKAN-YSBZUPOXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TNP-2092","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cbr-2092","Tnp-2092"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594563","drugType":"Unknown","blackBoxWarning":false,"name":"ISIS-463588","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IONIS-FGFR4RX","ISIS-463588","ISIS-FGFR4RX","Isis-463588","Isis-fgfr4rx"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650221","canonicalSmiles":"CC/C=C/C/C=C/C/C=C/C/C=C/C/C=C/CCCC(=O)O.CC/C=C/C/C=C/C/C=C/C/C=C/C/C=C/CCCCC(=O)O.CC/C=C/C/C=C/C/C=C/C/C=C/C/C=C/CCCCCC(=O)O","inchiKey":"MSHVEAAKYBMOTM-VVUKEZRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMEGA-3-PENTAENOIC ACIDS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MAT-9001","MAT9001","Omega-3-pentaenoic acids"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650355","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])Cc1cc(CCC(=O)NCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)ccc1O)Cc1cc(CCC(=O)O)ccc1O.[18F-].[Al+3]","inchiKey":"XIWCYNLURQSGJS-OECGVUFTSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"GOZETOTIDE ALF-18","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3578202","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(al18f)psma-hbed","18f-psma","18f-psma-11","Al(18f)psma-11","Gozetotide alf-18","Psma-hbed-cc alf-18"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650426","drugType":"Unknown","blackBoxWarning":false,"name":"THOR-707","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Il-2 variant thor-707","SAR-444245","SAR444245","THOR-707","Thor-707"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650471","drugType":"Unknown","blackBoxWarning":false,"name":"HPN-424","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HPN-424","HPN424","Hpn-424","Hpn424"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL47050","canonicalSmiles":"OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"MDLAAYDRRZXJIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENFLURIDOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Semap"],"synonyms":["MCN-JR-16,341","MCN-JR-16341","Micefal","NSC-759179","Penfluridol","R 16,341","R-16341","Semap"],"crossReferences":{"PubChem":["144207095","170466197","29217623"],"Wikipedia":["Penfluridol"],"drugbank":["DB13791"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4744254","canonicalSmiles":"C[C@H](NS(=O)(=O)c1cc(C(=O)Nc2ccc(F)c(C#N)c2)n(C)c1)C(F)(F)F","inchiKey":"SBVBIDUKSBJYEF-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERSACAPAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bersacapavir","JNJ-56136379","JNJ-6379","Jnj-56136379"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL478409","canonicalSmiles":"COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1","inchiKey":"LDXLQEXLXZCYSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478409","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07790"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL479014","canonicalSmiles":"O=[N+]([O-])c1cccc2c(Br)n[nH]c12","inchiKey":"NFSTZPMYAZRZPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL479014","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110834","11113670","124879386","124879387","124879390","26747128","26751855","26751856","50104555","50104556","50104557","50104558","85230935","90341482"],"drugbank":["DB01997"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483161","canonicalSmiles":"COc1ccccc1-c1ccc(NC(=O)/C(C#N)=C(/C)O)c(Cl)c1","inchiKey":"YUDQXOMZBLEWBH-KAMYIIQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL483161","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08172"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485940","canonicalSmiles":"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(C)n1","inchiKey":"QKLSCPPJEVXONT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMETOMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfamethomidine","Sulfametomidine"],"crossReferences":{"PubChem":["144206847"],"Wikipedia":["Sulfametomidine"],"drugbank":["DB13485"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL492762","canonicalSmiles":"COc1cc(=O)n(C)c2c3c(ccc12)OCO3","inchiKey":"DPXXJCMMMXZVSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASIMIROIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Casimiroin"],"crossReferences":{"drugbank":["DB08744"],"chEBI":["3452"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL496102","canonicalSmiles":"COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1","inchiKey":"HEAIZQNMNCHNFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-208","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-208","Amg 208","Amg-208","Amg208"],"crossReferences":{"PubChem":["174006590"],"drugbank":["DB08079"],"chEBI":["90626"]},"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL496574","canonicalSmiles":"CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1","inchiKey":"KQGTYXRWSIBDOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL496574","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL503160","canonicalSmiles":"O=C(O)/C=C/C(=O)O","inchiKey":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUMARIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["2-butenedioic acid, (e)-","Allomaleic-acid","Boletic-acid","E-297","E297","FEMA NO. 2488","Fumarate","Fumaric Acid","Fumaric acid","Fumaricum acidum","INS NO.297","INS-297","Monosodium fumarate","NSC-2752"],"crossReferences":{"PubChem":["144208967","144213143","17389670","69355","85148759"],"Wikipedia":["Fumaric_acid"],"drugbank":["DB01677"],"chEBI":["18012"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psoriasis and has 1 investigational indication."}
{"id":"CHEMBL513225","canonicalSmiles":"O=C(c1c(O)cc(O)cc1O)n1cccc1","inchiKey":"RYGSNHBTZDYVSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL513225","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08443"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL517712","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2","inchiKey":"RKUNBYITZUJHSG-SPUOUPEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATROPINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atroject","Atropen","Atrophate","Atropine","Atropine (autoinjector)","Isopto Atropine"],"synonyms":["Atropine","Atropinum","Dl-hyoscyamine"],"crossReferences":{"DailyMed":["atropine","atropine%20sulfate"],"PubChem":["11533003","144204367","144205143","144207685","56422449"],"drugbank":["DB00572"],"chEBI":["16684"]},"childChemblIds":["CHEMBL1200752","CHEMBL2146146","CHEMBL3185794","CHEMBL3182372"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":3},"linkedDiseases":{"rows":["HP_0000545","EFO_0005252","MONDO_0007254","EFO_1000644","HP_0004398","HP_0100543","EFO_1001865","EFO_0005758","MONDO_0005180","EFO_1000645","EFO_0010581","EFO_0008546","MONDO_0004976","HP_0011499","EFO_0005854","EFO_0004210","HP_0001662","HP_0000486","EFO_0009512","EFO_0005323","MONDO_0001020","HP_0002571","EFO_1001109","HP_0012803","EFO_0003843","HP_0002315","MP_0001914","EFO_0000304","EFO_0010282","EFO_0002614","Orphanet_230","EFO_1001121","EFO_0004888","EFO_0004209","HP_0001943","EFO_0009314","GO_0007596","EFO_0009492","EFO_0003956"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 7 approved and 23 investigational indications."}
{"id":"CHEMBL523395","canonicalSmiles":"O=C(Nc1ccccc1C(=O)O)c1cccc(S(=O)(=O)N2CCc3ccccc3C2)c1","inchiKey":"GYILVHHTCYNIOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW9371","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW9371"],"crossReferences":{"drugbank":["DB07691"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539648","canonicalSmiles":"O=C(O)/C=C\\C(=O)O","inchiKey":"VZCYOOQTPOCHFL-UPHRSURJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALEIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maleic Acid"],"crossReferences":{"PubChem":["144206656","144209391","144213362","170465983","17389671","57268340"],"Wikipedia":["Maleic_acid"],"drugbank":["DB04299"],"chEBI":["18300"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL583207","canonicalSmiles":"COc1ccc([C@@]23Oc4cc(OC)cc(OC)c4[C@]2(O)[C@H](O)[C@H](C(N)=O)[C@H]3c2ccccc2)cc1","inchiKey":"RMNPQEWLGQURNX-PXIJUOARSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIDESMETHYLROCAGLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Didesmethylrocaglamide"],"crossReferences":{"PubChem":["528941"],"drugbank":["DB15496"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL585902","canonicalSmiles":"Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O","inchiKey":"RQVKVJIRFKVPBF-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-548","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-548","Amg-548"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL588934","canonicalSmiles":"CC[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12","inchiKey":"LJOQGZACKSYWCH-WZBLMQSHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL588934","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13718"]},"childChemblIds":["CHEMBL596731"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL65567","canonicalSmiles":"CN1CC(=O)N=C1N","inchiKey":"DDRJAANPRJIHGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CREATININE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-methylglycocyamidine","1-methylhydantoin-2-imide","Creatinine","Kreatininum","NSC-13123"],"crossReferences":{"PubChem":["144205069","170466777","26749779","50085985"],"Wikipedia":["Creatinine"],"drugbank":["DB11846"],"chEBI":["16737"]},"childChemblIds":["CHEMBL1518203"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL68117","canonicalSmiles":"CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC","inchiKey":"XZAFZXJXZHRNAQ-STQMWFEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOSAROXIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-7352","SNS-595","SPC-595","Voreloxin","Vosaroxin"],"crossReferences":{"drugbank":["DB11999"]},"childChemblIds":["CHEMBL543336"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000565","EFO_0000339","EFO_0000220","EFO_0000702","EFO_0000222","EFO_0003060"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL719","canonicalSmiles":"C/C(=C\\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O","inchiKey":"MINDHVHHQZYEEK-HBBNESRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MUPIROCIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bactroban","Centany","Mupirocin"],"synonyms":["BRL 4910A","BRL-4910A","Bactoderm","Bactroban","Mupirocin","NSC-759182","Pseudomonic acid","Trans-pseudomonic acid","Turixin"],"crossReferences":{"DailyMed":["mupirocin","mupirocin%20calcium"],"PubChem":["144205736","47193668","50111691"],"Wikipedia":["Mupirocin"],"drugbank":["DB00410"],"chEBI":["7025"]},"childChemblIds":["CHEMBL3989715","CHEMBL2068726"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 3 approved and 9 investigational indications."}
{"id":"CHEMBL75753","canonicalSmiles":"O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1","inchiKey":"DXPOSRCHIDYWHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XAMOTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ICI-118,587","ICI-118587","Xamoterol"],"crossReferences":{"PubChem":["104171266","144203855"],"Wikipedia":["Xamoterol"],"drugbank":["DB13781"],"chEBI":["10055"]},"childChemblIds":["CHEMBL1329567","CHEMBL1256945","CHEMBL2104466"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL79993","canonicalSmiles":"O=C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1","inchiKey":"ORZXYSPOAVJYRU-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Z-PRO-PROLINAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JTP-4819"],"crossReferences":{"PubChem":["26756775"],"drugbank":["DB03535"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL945","canonicalSmiles":"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N","inchiKey":"XSDQTOBWRPYKKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMILORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amiclaran","Amiloride","Hydro-Ride","Midamor"],"crossReferences":{"DailyMed":["amiloride%20hydrochloride"],"PubChem":["104171108","11110775","11113372","124879259","124879263","144203631","170465124","26751628","26751629","49645530","90341609"],"Wikipedia":["Amiloride"],"drugbank":["DB00594"],"chEBI":["2639"]},"childChemblIds":["CHEMBL1398126","CHEMBL1201085","CHEMBL540851"],"linkedTargets":{"rows":["ENSG00000111319"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0007405","EFO_0004269","HP_0000093","EFO_0001645","Orphanet_586","EFO_0000373","EFO_0000319","EFO_1001496","EFO_0000537","EFO_0000289","MONDO_0001134","EFO_0008519","HP_0011096","EFO_0003884","EFO_0008522","MONDO_0005475"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL984","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2.[Cl-].[Cl-]","inchiKey":"WMSYWJSZGVOIJW-ONUALHDOSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVACURIUM CHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1182833","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mivacron","Mivacurium chloride"],"synonyms":["BW B109OU DICHLORIDE","BW-1090U DICHLORIDE","BW-B109OU","BW-B109OU DICHLORIDE","BWB109OU","Mivacurium chloride","mivacurium"],"crossReferences":{"PubChem":["144206026"],"Wikipedia":["Mivacurium_chloride"]},"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0001410"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and has 1 investigational indication."}
